Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
Clinical trial NCT03446261 · COMPLETED
Trial details
- NCT number
- NCT03446261
- Sponsor
- Yuhan Corporation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-23
- Primary completion
- 2019-03-05
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.